Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
46. Eisman JA. Genetics of osteoporosis. Endocr Rev. 1999;20:788-804.
47. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum
markers of type I collagen formation and degradation in metabolic bone disease:
correlation with bone histomorphometry. J Bone Miner Res. 1993;8:127-32.
48. Eskandari F, Martinez PE, Torvik S, et al. Low bone mass in premenopausal
women with depression. Arch Intern Med. 2007;167:2329-36.
49. Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone-massrelated
risk factors for fracture to guide bone densitometry measurements: a systematic
review of the literature. Osteoporos Int. 2001;12:811-22.
50. Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF.
Patterns of personality disorder comorbidity in early-onset versus late-onset major
depression. Am J Psychiatry. 1996;153:1308-12.
51. Fogelholm M, Sievanen H, Heinonen A, et al. Association between weight
cycling history and bone mineral density in premenopausal women. Osteoporos Int.
1997;7:354-8.
52. Francis DD, Caldji C, Champagne F, Plotsky PM, Meaney MJ. The role of
corticotropin-releasing factor--norepinephrine systems in mediating the effects of early
experience on the development of behavioral and endocrine responses to stress. Biol
Psychiatry. 1999;46:1153-66.
53. Frankenburg FR, Zanarini MC. Personality disorders and medical comorbidity.
Curr Opin Psychiatry. 2006;19:428-31.
54. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M.
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between
the acute state and after remission. Eur Arch Psychiatry Clin Neurosci. 1997;247:228-33.
55. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFalpha potently
activates osteoclasts, through a direct action independent of and strongly synergistic with
RANKL. Endocrinology. 2002;143:1108-18.
56. Garcia-Carrasco Mea. Calcif.TissueInt. 1996;59:2-9.
64